United States · 
Who invested in Locus Biosciences?
Locus Biosciences's investors include Abstract Ventures, Tengxun Touzi, Artis Ventures (AV), Hercules Capital and Viking Global, and 2 more on record.
20182019202020212022
$19MSeries A$35MSeries BUnited States · Series B startup
Who invested in Locus Biosciences
Funding summaryUpdated 26 Oct 2026
$54Mraised across 2 rounds since 2017, from 2 sources
$19MSeries A$35MSeries B
- Latest round
- Series B, $35MMay 2022
- Step-upi
- 1.8×
- Investors
- 7
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $19M Nov 2017
- Biggest round
- $35M Series B · May 2022
- Between rounds
- 4.5 years from the last two
The rounds
- May 2022Series B$35M4 new1 returning
Source recordedSEC filing: $11M sold, first sale Jan 2022
- Nov 2017Series A$19M3 new
Abstract Ventures- Artis Ventures/ Tencent
- North Carolina Biotechnology
Reported by FinSMEsSEC filing: $7.0M sold, first sale Sept 2017
Founders and team
From Locus Biosciences's own website and the SEC filings it signed: 23 on the team.
- Jamie KimeVice President, Clinical Operations and CMC Operations
- Tamara MonesmithSenior Vice President, Chemistry, Manufacturing, and Controls
- Aaron StepanekAssociate Scientist
- Alexander PantelakosFinancial Analyst
- Austin WalneDirector
- Blair CapelDirector of Finance
- Brandy BarberResearch Associate II
- Charity BassQuality Associate
- Dalena NguyenAssociate Development Scientist
- Daniel MunAssociate Development Scientist
- Julia TrautmanSenior Director, Research and Development Program Management
- Luke SobolewskiDirector of Development
- Matthew SweedeDirector of Business Development and Strategy
- Megan FrisbeeResearch Associate I
- Michelle BaldassareResearch Associate
- Morgan WallData Engineer
- Naomi Chavez CastilloResearch Associate
- Nathan MacGregorAssociate Director of Quality
And 5 more on the team.
On the board, as filediStuart Peterson
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2017Series B2022Abstract Ventures
Tengxun Touzi
Artis Ventures (AV)
Hercules Capital
Viking GlobalArtis Ventures/ TencentNorth Carolina Biotechnology
Abstract VenturesTengxun TouziArtis Ventures (AV)Hercules CapitalViking GlobalArtis Ventures/ TencentNorth Carolina BiotechnologyEveryone who backed them
Artis Ventures/ Tencentno record of our own yet1round
North Carolina Biotechnologyno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Locus Biosciences as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Locus Biosciences
How much has Locus Biosciences raised?
Locus Biosciences has raised $54M across 2 rounds since 2017.
When did Locus Biosciences last raise?
Locus Biosciences's most recent round was a Series B of $35M in May 2022.
What was Locus Biosciences's biggest round?
Its most recent round, $35M in May 2022, is also its largest on record.
Who backed Locus Biosciences first?
Locus Biosciences's first round on record, in Nov 2017, was backed by Abstract Ventures, Artis Ventures/ Tencent and North Carolina Biotechnology.
What stage is Locus Biosciences at?
Locus Biosciences's latest named round is a Series B, in May 2022.
Where is Locus Biosciences based?
Locus Biosciences is based in the United States.
Companies like Locus Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.